| Eugene H Lewis Iii, DO | |
|
2800 Main St, St. Vincent's Medical Center, Dept. Of Pathology, Bridgeport, CT 06606-4201 | |
| (203) 576-5033 | |
| Not Available |
| Full Name | Eugene H Lewis Iii |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 24 Years |
| Location | 2800 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609830470 | NPI | - | NPPES |
| 001431858 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 043185 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Hartford Hospital | Hartford, CT | Hospital |
| Griffin Hospital | Derby, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairfield County Pathology Consultants, Llc | 7113969833 | 4 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.
Representatives of Ohio University and Columbus State Community College (CSCC) signed an agreement to form the Pathways Institute Partnership on Wednesday, April 28, in Athens.
Dr. Sabrina Coninx from Ruhr-Universität Bochum and Dr. Peter Stilwell from McGill University, Canada, have investigated how philosophical approaches can be used to think in new ways about pain and its management.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
› Verified 7 days ago
| Entity Name | Gastroenterology Associates Of Fairfield Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285710442 PECOS PAC ID: 3274506290 Enrollment ID: O20040818000151 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.
Representatives of Ohio University and Columbus State Community College (CSCC) signed an agreement to form the Pathways Institute Partnership on Wednesday, April 28, in Athens.
Dr. Sabrina Coninx from Ruhr-Universität Bochum and Dr. Peter Stilwell from McGill University, Canada, have investigated how philosophical approaches can be used to think in new ways about pain and its management.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
› Verified 7 days ago
| Entity Name | Fairfield County Pathology Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518064757 PECOS PAC ID: 7113969833 Enrollment ID: O20050524000533 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.
Representatives of Ohio University and Columbus State Community College (CSCC) signed an agreement to form the Pathways Institute Partnership on Wednesday, April 28, in Athens.
Dr. Sabrina Coninx from Ruhr-Universität Bochum and Dr. Peter Stilwell from McGill University, Canada, have investigated how philosophical approaches can be used to think in new ways about pain and its management.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
› Verified 7 days ago
| Entity Name | Connecticut Gi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023124625 PECOS PAC ID: 9830110758 Enrollment ID: O20070112000011 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.
Representatives of Ohio University and Columbus State Community College (CSCC) signed an agreement to form the Pathways Institute Partnership on Wednesday, April 28, in Athens.
Dr. Sabrina Coninx from Ruhr-Universität Bochum and Dr. Peter Stilwell from McGill University, Canada, have investigated how philosophical approaches can be used to think in new ways about pain and its management.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eugene H Lewis Iii, DO 2800 Main St, St. Vincent's Medical Center, Dept. Of Pathology, Bridgeport, CT 06606-4201 Ph: (203) 576-5033 | Eugene H Lewis Iii, DO 2800 Main St, St. Vincent's Medical Center, Dept. Of Pathology, Bridgeport, CT 06606-4201 Ph: (203) 576-5033 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.
Representatives of Ohio University and Columbus State Community College (CSCC) signed an agreement to form the Pathways Institute Partnership on Wednesday, April 28, in Athens.
Dr. Sabrina Coninx from Ruhr-Universität Bochum and Dr. Peter Stilwell from McGill University, Canada, have investigated how philosophical approaches can be used to think in new ways about pain and its management.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
› Verified 7 days ago
Dr. Christine Marianne Minerowicz, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3156 Fax: 203-384-3237 | |
Young Choi Kim, MD Pathology Medicare: Medicare Enrolled Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3157 Fax: 203-384-3237 | |
Dr. George Michael Golenwsky, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-5033 | |
Dr. Saurabh Malhotra, MD Pathology Medicare: Medicare Enrolled Practice Location: 2800 Main St Dept Of, Bridgeport, CT 06606 Phone: 203-576-5033 | |
Dr. Angelique W Levi, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, St. Vincent's Medical Center, Dept. Of Pathology, Bridgeport, CT 06606 Phone: 203-576-5033 | |
Sumi Varghese Thomas, M.B.B.S Pathology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 732-235-8120 | |
Agedi Nicholson Boto, M.D./PH.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 475-210-5032 Fax: 475-210-5034 |